ACE and diabetic kidney disease: RAAS inhibitors have been the treatment of choice for DKD, following the publication of clinical trial results demonstrating benefits of angiotensin converting enzyme inhibitors and angiotensin receptor blockers for decreasing albuminuria in patients with DKD (157).